| Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias MR Ricciardi, S Mirabilii, M Allegretti, R Licchetta, A Calarco, MR Torrisi, ... Blood, The Journal of the American Society of Hematology 126 (16), 1925-1929, 2015 | 210 | 2015 |
| Liquid biopsy and PCR-free ultrasensitive detection systems in oncology A Finotti, M Allegretti, J Gasparello, P Giacomini, DA Spandidos, G Spoto, ... International Journal of Oncology 53 (4), 1395-1434, 2018 | 79 | 2018 |
| Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations M Allegretti, A Fabi, S Buglioni, A Martayan, L Conti, E Pescarmona, ... Journal of Experimental & Clinical Cancer Research 37, 1-3, 2018 | 64 | 2018 |
| The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia M Allegretti, MR Ricciardi, R Licchetta, S Mirabilii, S Orecchioni, ... Scientific reports 5 (1), 18137, 2015 | 46 | 2015 |
| Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia S Iacovelli, MR Ricciardi, M Allegretti, S Mirabilii, R Licchetta, P Bergamo, ... Oncotarget 6 (31), 32089, 2015 | 38 | 2015 |
| Precision diagnostics of Ewing’s sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts M Allegretti, B Casini, C Mandoj, S Benini, L Alberti, M Novello, E Melucci, ... Therapeutic Advances in Medical Oncology 10, 1758835918774337, 2018 | 35 | 2018 |
| A distinctive microRNA (miRNA) signature in the blood of colorectal cancer (CRC) patients at surgery J Gasparello, C Papi, M Allegretti, E Giordani, F Carboni, S Zazza, ... Cancers 12 (9), 2410, 2020 | 34 | 2020 |
| Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA) J Gasparello, M Allegretti, E Tremante, E Fabbri, CA Amoreo, P Romania, ... Journal of Experimental & Clinical Cancer Research 37, 1-11, 2018 | 32 | 2018 |
| Direct plasmonic detection of circulating RAS mutated DNA in colorectal cancer patients R D'Agata, N Bellassai, M Allegretti, A Rozzi, S Korom, A Manicardi, ... Biosensors and Bioelectronics 170, 112648, 2020 | 31 | 2020 |
| Detection of tumor DNA in human plasma with a functional PLL-based surface layer and plasmonic biosensing N Bellassai, R D’Agata, A Marti, A Rozzi, S Volpi, M Allegretti, R Corradini, ... ACS sensors 6 (6), 2307-2319, 2021 | 26 | 2021 |
| Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy M Allegretti, G Cottone, F Carboni, E Cotroneo, B Casini, E Giordani, ... Journal of Experimental & Clinical Cancer Research 39, 1-12, 2020 | 26 | 2020 |
| Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer M Allegretti, A Fabi, E Giordani, C Ercolani, P Romania, C Nisticò, ... Molecular Cancer 20, 1-6, 2021 | 12 | 2021 |
| Bioassay engineering: a combined label-free and fluorescence approach to optimize HER2 detection in complex biological media A Sinibaldi, A Doricchi, T Pileri, M Allegretti, N Danz, P Munzert, ... Analytical and Bioanalytical Chemistry 412, 3509-3517, 2020 | 9 | 2020 |
| Foa MR Ricciardi, S Mirabilii, M Allegretti, R Licchetta, A Calarco, MR Torrisi R., Nicolai, R., Peluso, G., and Tafuri, A, 1925-1929, 2015 | 6 | 2015 |
| Detection of anti-SARS CoV-2 antibodies in human serum by means of Bloch surface waves on 1D photonic crystal biochips A Occhicone, A Sinibaldi, D Chiappetta, P Di Matteo, T Pileri, N Danz, ... Biosensors and Bioelectronics: X 15, 100413, 2023 | 4 | 2023 |
| Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients A Sacconi, P Muti, C Pulito, G Urbani, M Allegretti, R Pellini, N Mehterov, ... Molecular Cancer 22 (1), 192, 2023 | 4 | 2023 |
| Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis B Cerbelli, A Pisano, MG Pignataro, A Pernazza, A Botticelli, M Carosi, ... Clinical and Experimental Medicine 23 (5), 1641-1647, 2023 | 4 | 2023 |
| The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world P Giacomini, F Valenti, M Allegretti, M Pallocca, F De Nicola, L Ciuffreda, ... Journal of Translational Medicine 21 (1), 725, 2023 | 3 | 2023 |
| TOOLBOX: Strep-Tagged nano-assemblies of antibody-drug-conjugates (ADC) for modular and conditional cancer drugging E Tremante, L Sibilio, F Centola, N Knutti, G Holzapfel, I Manni, ... Oncology reports 45 (5), 77, 2021 | 3 | 2021 |
| Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood. F Ganci, M Allegretti, V Manciocco, F Fiorentino, G Sanguineti, ... Oral Oncology 115, 105096-105096, 2020 | 3 | 2020 |
